Homepage / Technology / Silicon Valley's biggest start-up factory is making a bet on biotech, but it's not an obvious fit
Deneme Bonusu Veren Siteler Deneme Bonusu 2024 Explore the Magic of WildCardCity Güvenilir Bahis Siteleri En İyi Kumar Siteleri Balıkesir Triatlonuna Avrupadan Ödül Tricks of the Aviator gambling establishment game by Spribe Çevrim Içi Kumar Siteleri “bonus” Yalanıyla Kandırıyor En Güvenilir Canlı On Line Casino Siteleri Xbetting-tips Com Uncovering the Abundant Tapestry of Ozwin Gambling establishment Evaluating Board Portal Providers Uncovering the Wealthy Tapestry of Ozwin On line casino Electronic Data Area Providers Evaluation Cobra Internet casino: Raising the Australian On the internet Video gaming Practical experience 4 Things to Search for in Safeguarded Cloud Safe-keeping Fastpay On line casino Australia – Simple and No-Taxation Wagering Web page officielle franзaise de Joka Gambling establishment The Software Development Universe Game Woo Internet casino – Enjoy Slot machine games around australia Ostdeutsche Biersorten What Are Virtual Data Rooms? Vitamin D Receptor Polymorphisms Revue du Casino BlackLabel Faktory, kterй ovlivnujн hodnocenн ceskэch online kasin How to Make the Most of Your Web Development Organization and Advertising Efforts L’essor des casinos en ligne en France Boost Meeting Efficiency With Boardroom Technology Developments WildJoker Casino WildCardCity On line casino – Guaranteed Australian Gambling Portal WildCardCity Casino – The Ideal On the internet Gambling establishment within australia Modern Technologies Produce Sharing Documents Online Faster and More Protect Free Virtual Info Room pertaining to Speedy Due Diligence A Review of Data Area Software For people who do buiness Five Board Bedroom Features Which will help You Acquire a More Productive Boardroom Electronic Systems To your Business Understanding Legal Terms and Laws in Today’s World The Laws and Contracts of Hollywood: A Sunset Blvd. Tale Legal Discussion Between Johnny Cash and Antonin Scalia Legal Insights: What Teens Should Know Legal Issues and Exceptions: What You Need to Know Legal Insights and Expert Analysis Celebrity Dialogue: Legal Matters in the 21st Century Famous Personalities Discuss Legal Issues The Boys in the Boat: Legal Advisors and The Quest for Legal Knowledge Understanding Legal Matters: Q&A on Criminal Law, Joint Ventures, and More Enticing Title The Departed: Understanding Basic Work Requirements and Legal Rights Youth Slang Blog Article Legal Insights: A Journey into the World of Law The Ins and Outs of Legal Matters: Everything You Need to Know Legal Insights and Trends: A Rap Guide Mysterious Legal Matters Unveiled Insights and Information: Understanding Various Laws and Regulations Famous People of the 21st Century The Circle of Legal Life The Intersection of Fashion Law, Legal Translation, and THC Oil: A Modern Legal Guide Legal Q&A: Understanding Joinder Federal Rules and More Understanding Legal Terms and Conditions: A Comprehensive Guide Understanding Legal Documentation in a Fun Way! Understanding Legal Aspects: From Islamic Law of Inheritance to Farm Law Protests Understanding Legal Rights: A Guide to Legal Regulations and Requirements Understanding Legal Guidelines and Agreements Famous 21st Century People in Conversation Mysterious Legal Matters Unveiled Legal Matters and Real Estate: A Conversation Between Cameron Boyce and Donald Trump Understanding Legal Expertise and Why It Matters Legal FAQs and Expert Services Understanding Legal Ramifications: Common Law Ontario Health Benefits and More The Ins and Outs of Legal Requirements: From FBI Academy Physical Requirements to Silver Lake Fishing Rules The Legal Underworld: Understanding the Significance of Laws and Rights Legal Conversations: A Dialogue Between Jon Jones and Chadwick Boseman Legal Beats: Bobcats, Real Estate, Babysitting, and More Legal Matters and Netflix VPN Diabolique: Legal Affairs and Deception Ben Shapiro and Eddie Van Halen Discuss Legal Matters Legal Aid and Other Legal Issues Q&A Famous 21st Century Personalities in Dialogue Youthful Blog Post Expert Legal Insights: Top 8 Law Firms in Australia, Quasi Contracts, and More! Youth Slang in Legal Matters Steps to make Your Mother board Room Even more Productive and Meaningful Choosing Data Rooms for Homework The Enigmatic World of Legal Affairs and Contracting The Mystery of Legal Matters Understanding Legal Mandates and Guidelines in the Business World Celebrity Dialogue: Legal Matters and Personal Names Legal Questions: Answered! Mysterious Legal Insights and Tips The Mysterious World of Legal Agreements Legal Lingo: Reviews, Agreements, and More Exploring Legal Education and Responsibilities: A Comprehensive Guide Unconventional Wisdom: A Dialog Between 21st Century Icons Mysterious Legal Matters Unraveled The Legal Maze: Navigating the Legal Landscape Dialogue between Jared Kushner and Vasyl Lomachenko Legal Matters: A Conversation Between Prince and Lionel Messi Get Clued In: The Legal Lowdown for Gen Z Famous People of the 21st Century Talk About Legal Matters The Enigmatic World of Legal Agreements and Terms Are You Breaking the Law? Unusual Legal Questions Answered Understanding Legal Services, Parental Responsibility Laws, and More Understanding Legal Agreements and Requirements

Technology

Silicon Valley's biggest start-up factory is making a bet on biotech, but it's not an obvious fit

Y Combinator, Silicon Valley’s best known start-up accelerator, thinks it has found a new type of biotechnology start-up.

Life-sciences companies come with a high risk of failure—often, the science behind a proposed invention isn’t entirely proven, and turns out not to work. Because of this risk, the traditional way to fund early-stage life sciences companies is for a landmark East Coast investor, such as Third Rock or Flagship, to take a huge equity stake in the business and replace the founder with a seasoned executive. In exchange, it pumps tens of millions of dollars into the company over many years. It often takes more than a decade to generate a return.

But YC is betting that biotech start-ups that use the latest computer science technologies such as machine learning, will grow much more quickly than their counterparts, and thus should be funded more like tech start-ups.

A classic example is YC’s first biotech company: Ginkgo Bioworks, which bills itself as scaling the process of organism engineering using “software and hardware automation.” After graduating from YC in 2014, the company went on to raise more than $150 million from tech investors including Felicis Ventures and Data Collective.

Biotech is is now a serious category for the fund. Y Combinator is about to add another part-time partner with health and biotech expertise to its ranks, alongside existing partner Elizabeth Iorns (Altman declined to name them, as the plans have not yet been finalized).

“When I took over YC in 2014 I made a list of things I wanted to get into,” said the company’s president Sam Altman. “Health and synthetic biologies were two of the categories.”

Y Combinator’s interest in biotech came at an ideal time.

In the past few years, Sand Hill Road investors ranging from Andreessen Horowitz to GV (formerly Google Ventures) are eyeing companies that bring advanced computing to areas like disease detection and drug development, which they hope will scale at fraction of the cost than traditional biotech companies.

CRV investor George Zachary is also a convert, recently shifting his focus from tech to companies that are “advancing health through computer science.”

Altman said it wasn’t always this way. “When we started funding bio companies, Sand Hill Road hadn’t decided they liked it yet,” he explained. “But it turns out that there was interest in a few years from West Coast tech.”‘

But so far, YC’s biotech founders have found only mixed success appealing to Silicon Valley.

YC graduate Ethan Perlstein is currently fundraising for Perlara, a start-up that is focused on finding treatments for rare diseases. In his experience, it has been a challenge for many Y Combinator alumni in the sector to raise their first big round of venture financing. Sand Hill Road’s investors will open the door, he said, but few are willing to write a big check for a first round.

YC’s partners acknowledged the challenge, but said it isn’t unique to its health care companies.

“I think that raising a true series A round is challenging for a lot of companies right now, which isn’t specific to therapeutics,” explained Iorns, CEO of a start-up called Science Exchange and a part-time partner at Y Combinator.

Iorns said Y Combinator companies that have an “element of machine learning or computational biology” are actually among the most sought-after overall. That’s in large part due to the success of cancer drug development start-up Stemcentrx, which sold in 2016 for $10.2 billion to AbbVie. Stemcentrx, which was funded in 2008, claimes to use “new technologies and paradigms” to discover new drug therapies.

But biotech is an uneasy fit for a culture steeped in software, and online companies that can turn on a dime.

Unlike traditional biotech start-ups, which remain in stealth mode for years until they get strong scientific evidence to back up their claims, start-ups that get accepted into the Y Combinator’s must demo a minimally viable product in 3 months.

Some outsiders are skeptical.

“YC wants to fund tech people that do biotech, rather than embracing what it takes to do biotech,” said Ryan Bethencourt, venture partner with IndieBio, an accelerator program that focuses on synthetic biology companies.

“But YC doesn’t have the expertise to tackle an established industry with regulatory hurdles, pricing and reimbursement complexities,” he added. “They haven’t changed the model enough to reliably build therapeutics companies.”

Altman said that Y Combinator recognizes that health companies have some unique challenges relative to tech — and that “it takes longer” than other sectors. But he also believes there are some aspects of the business that can be done quickly, such as getting introductions to potential customers for early pilots. He also thinks the opportunity is too huge to pass up.

“I’m super excited about the entrepreneurial focus in health and biotech,” he said. “It’s one of these mind-blowing moments where we’re not that far away from an A.I. doctor.”

Source: Tech CNBC
Silicon Valley's biggest start-up factory is making a bet on biotech, but it's not an obvious fit

Comments are closed.